Article Type
Changed
Fri, 01/04/2019 - 11:11
Display Headline
David Henry's JCSO podcast, July 2015

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses a Community Translations article on lenvatinib, which was approved earlier this year for the treatment of patients with advanced differentiated thyroid cancer whose disease has progressed after radioactive iodine therapy. Also in the line-up are two Original Reports, one on health care expenditures associated with depression in adults with cancer and another on maximizing accessibility to and the efficacy of a weekly speech and language therapy service for patients with head and neck cancer who are receiving radiotherapy. A Case Report on a patient with inflammatory metastatic breast cancer with gallbladder metastases, a Feature article on new lung cancer treatments, and a summary of key findings from the 2015 annual meeting of the American Society of Clinical Oncology, round off the podcast.

References

Author and Disclosure Information

Audio / Podcast
Publications
Topics
Legacy Keywords
lenvatinib, differentiated thyroid cancer, DTC, radioactive iodine therapy, health care expenditures, depression, adults with cancer, speech and language therapy, S&L, head and neck cancer, radiotherapy, inflammatory breast cancer, gallbladder metastases, lung cancer

Sections
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses a Community Translations article on lenvatinib, which was approved earlier this year for the treatment of patients with advanced differentiated thyroid cancer whose disease has progressed after radioactive iodine therapy. Also in the line-up are two Original Reports, one on health care expenditures associated with depression in adults with cancer and another on maximizing accessibility to and the efficacy of a weekly speech and language therapy service for patients with head and neck cancer who are receiving radiotherapy. A Case Report on a patient with inflammatory metastatic breast cancer with gallbladder metastases, a Feature article on new lung cancer treatments, and a summary of key findings from the 2015 annual meeting of the American Society of Clinical Oncology, round off the podcast.

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses a Community Translations article on lenvatinib, which was approved earlier this year for the treatment of patients with advanced differentiated thyroid cancer whose disease has progressed after radioactive iodine therapy. Also in the line-up are two Original Reports, one on health care expenditures associated with depression in adults with cancer and another on maximizing accessibility to and the efficacy of a weekly speech and language therapy service for patients with head and neck cancer who are receiving radiotherapy. A Case Report on a patient with inflammatory metastatic breast cancer with gallbladder metastases, a Feature article on new lung cancer treatments, and a summary of key findings from the 2015 annual meeting of the American Society of Clinical Oncology, round off the podcast.

References

References

Publications
Publications
Topics
Article Type
Display Headline
David Henry's JCSO podcast, July 2015
Display Headline
David Henry's JCSO podcast, July 2015
Legacy Keywords
lenvatinib, differentiated thyroid cancer, DTC, radioactive iodine therapy, health care expenditures, depression, adults with cancer, speech and language therapy, S&L, head and neck cancer, radiotherapy, inflammatory breast cancer, gallbladder metastases, lung cancer

Legacy Keywords
lenvatinib, differentiated thyroid cancer, DTC, radioactive iodine therapy, health care expenditures, depression, adults with cancer, speech and language therapy, S&L, head and neck cancer, radiotherapy, inflammatory breast cancer, gallbladder metastases, lung cancer

Sections
Article Source

PURLs Copyright

Inside the Article